0708T Id ca immntx prep & first njx
Also known as: Immunotherapy candidate screening, Cancer immunotherapy prep, Initial immune therapy injection
Identification of cancer immunotherapy patient candidates with preparation and first injection.
In Plain Language
Testing if patient can receive immune therapy for cancer; Starting immunotherapy treatment for cancer
Clinical Context
Used for patient selection and initiation of cancer immunotherapy. Includes assessment of candidacy based on tumor and immune markers, plus first therapeutic injection.
RVU Information
CPT 0708T does not have a physician work RVU assigned by CMS. Category III codes for emerging technology do not receive RVU assignments. Reimbursement is negotiated with individual payers.
Billing & Documentation
Category III codes are temporary codes for emerging technology, services, and procedures. They are not assigned RVU values by CMS. Coverage and reimbursement vary by payer — check with individual insurers before billing. These codes sunset after 5 years if not converted to Category I.
Specialties
Frequently Asked Questions
What is CPT code 0708T?
CPT 0708T (Id ca immntx prep & first njx) is a Category III code. Identification of cancer immunotherapy patient candidates with preparation and first injection.
Is 0708T a permanent CPT code?
No — 0708T is a Category III temporary code for emerging technology. It may be converted to a permanent Category I code if widely adopted. Category III codes expire after 5 years without renewal.
When is CPT 0708T used?
Used for patient selection and initiation of cancer immunotherapy. Includes assessment of candidacy based on tumor and immune markers, plus first therapeutic injection.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.